Viatris Settles EpiPen Antitrust Litigation for $264 Million - The New York Times

The proposed settlement, which requires a judge’s approval, would resolve a legal battle that began after the company, in 2016, raised the price for two EpiPens to $608 from $100.

Neither Viatris officials nor lawyers representing the company immediately responded to a request for comment on Monday night. Updated Feb. 28, 2022, 4:58 p.m. ET Lynn Sarko, a lawyer representing … [+1314 chars]

full article...